Gregory J. Tawa

3.3k total citations
62 papers, 2.4k citations indexed

About

Gregory J. Tawa is a scholar working on Molecular Biology, Computational Theory and Mathematics and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Gregory J. Tawa has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 9 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Gregory J. Tawa's work include Computational Drug Discovery Methods (13 papers), Spectroscopy and Quantum Chemical Studies (7 papers) and Protein Structure and Dynamics (5 papers). Gregory J. Tawa is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Spectroscopy and Quantum Chemical Studies (7 papers) and Protein Structure and Dynamics (5 papers). Gregory J. Tawa collaborates with scholars based in United States, Canada and India. Gregory J. Tawa's co-authors include Anders Wallqvist, Igor A. Topol, S. K. Burt, A. A. Rashin, Hongmao Sun, R. A. CALDWELL, Mohamed Diwan M. AbdulHameed, Wei Zheng, Lawrence R. Pratt and Sidhartha Chaudhury and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and The Journal of Chemical Physics.

In The Last Decade

Gregory J. Tawa

61 papers receiving 2.4k citations

Peers

Gregory J. Tawa
Yixiang Cao United States
Benjamin A. Ellingson United States
Yuk Y. Sham United States
Joshua Williams United States
Wenbo Yu United States
Dean M. Philipp United States
Yixiang Cao United States
Gregory J. Tawa
Citations per year, relative to Gregory J. Tawa Gregory J. Tawa (= 1×) peers Yixiang Cao

Countries citing papers authored by Gregory J. Tawa

Since Specialization
Citations

This map shows the geographic impact of Gregory J. Tawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Tawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Tawa more than expected).

Fields of papers citing papers by Gregory J. Tawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Tawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Tawa. The network helps show where Gregory J. Tawa may publish in the future.

Co-authorship network of co-authors of Gregory J. Tawa

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Tawa. A scholar is included among the top collaborators of Gregory J. Tawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Tawa. Gregory J. Tawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tiwari, Sachchidanand, Neha Mehrotra, Ashish Thakur, et al.. (2023). Quatramer™ encapsulation of dual‐targeted PI3‐Kδ / HDAC6 inhibitor, HSB ‐510, suppresses growth of breast cancer. Bioengineering & Translational Medicine. 8(5). e10541–e10541. 6 indexed citations
2.
Watson, Daniel, Sharie J. Haugabook, Gregory J. Tawa, et al.. (2023). Rare disease variant curation from literature: assessing gaps with creatine transport deficiency in focus. BMC Genomics. 24(1). 460–460.
3.
Chen, Holly Y., Manju Swaroop, Hyun Beom Song, et al.. (2023). Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects. eLife. 12. 20 indexed citations
4.
Tawa, Gregory J., John Braisted, David Gerhold, et al.. (2021). Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species. PLoS Computational Biology. 17(9). e1009450–e1009450. 14 indexed citations
5.
Pace, Betty S., Susan P. Perrine, Yaqin Li, et al.. (2021). Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease. Blood Cells Molecules and Diseases. 89. 102561–102561. 7 indexed citations
6.
Bolanos, Lyndsey, Kathleen Hueneman, Morgan M. Walker, et al.. (2020). Targeting AML-associated FLT3 mutations with a type I kinase inhibitor. Journal of Clinical Investigation. 130(4). 2017–2023. 24 indexed citations
7.
Dai, Sheng, Shu Yang, Xin Hu, et al.. (2019). 17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells. Molecular Cancer Therapeutics. 18(7). 1265–1277. 7 indexed citations
8.
Sun, Wei, Shihua He, Carles Martínez‐Romero, et al.. (2016). Synergistic drug combination effectively blocks Ebola virus infection. Antiviral Research. 137. 165–172. 68 indexed citations
9.
Ippolito, Danielle L., Mohamed Diwan M. AbdulHameed, Gregory J. Tawa, et al.. (2015). Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis. Toxicological Sciences. 149(1). 67–88. 37 indexed citations
10.
Liu, Ruifeng, Narender Singh, Gregory J. Tawa, Anders Wallqvist, & Jaques Reifman. (2014). Exploiting large-scale drug-protein interaction information for computational drug repurposing. BMC Bioinformatics. 15(1). 210–210. 12 indexed citations
11.
AbdulHameed, Mohamed Diwan M., Gregory J. Tawa, Kamal Kumar, et al.. (2014). Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis. PLoS ONE. 9(11). e112193–e112193. 50 indexed citations
12.
Sirasani, Gopal, Manali Phadke, Natalia F. Krynetskaia, et al.. (2013). Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. Bioorganic & Medicinal Chemistry. 22(3). 1148–1155. 29 indexed citations
13.
Liu, Jin, Gregory J. Tawa, & Anders Wallqvist. (2013). Identifying Cytochrome P450 Functional Networks and Their Allosteric Regulatory Elements. PLoS ONE. 8(12). e81980–e81980. 32 indexed citations
14.
Singh, Narender, Hongmao Sun, Sidhartha Chaudhury, et al.. (2012). A physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space. Journal of Cheminformatics. 4(1). 4–4. 20 indexed citations
15.
Sun, Hongmao, Gregory J. Tawa, & Anders Wallqvist. (2011). Classification of scaffold-hopping approaches. Drug Discovery Today. 17(7-8). 310–324. 290 indexed citations
16.
Tawa, Gregory J., Junaid Baber, & Christine Humblet. (2009). Computation of 3D queries for ROCS based virtual screens. Journal of Computer-Aided Molecular Design. 23(12). 853–868. 27 indexed citations
17.
Chen, Jack J., Derek C. Cole, John W. Ellingboe, et al.. (2009). Identification of a new class of small molecule C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(2). 662–664. 5 indexed citations
18.
Childers, Wayne E., Arlene Dietrich, Boyd L. Harrison, et al.. (2009). 3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3. Bioorganic & Medicinal Chemistry. 17(22). 7755–7768. 18 indexed citations
19.
Marathias, Vasilios M., Gregory J. Tawa, Igor Goljer, & A. Bach. (2006). Stereochemical identification of (R)‐ and (S)‐ibuprofen using residual dipolar couplings, NMR, and modeling. Chirality. 19(9). 741–750. 33 indexed citations
20.
Cole, Derek C., Joseph R. Stock, John W. Ellingboe, et al.. (2005). Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(21). 4780–4785. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026